NEW PRACTICE GUIDANCE!
Singal A et al. @AASLDtweets Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
#LiverTwitter
tinyurl.com/3sz8akya
HEPATOLOGY Journal
4,665 posts
HEPATOLOGY: Official journal of AASLD (@AASLDtweets) covering liver diseases, hepatitis, cancer, cirrhosis, drug metabolism, and immunology #AASLDJournals
- REVIEW Controversies regarding albumin therapy in cirrhosis #JonelTrebicka @ggarciatsao #LiverTwitter tinyurl.com/2j2burcu
- 🚨 @AASLDtweets Practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis 🚨 JUST RELEASED shorturl.at/agEI1 #LiverTwitter #LiverX
- REVIEW: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC Suzanne Sharpton & @DrLoomba #LiverTwitter tinyurl.com/2fj8a93j
- Just released! Don't miss it! New #MASLDNomenclature! by @AASLDtweets at @Hep_Journal: [journals.lww.com/hep/10.1097/HE…] in a joint publication with @alehlatam @EASLnews #LiverTwitter
- REVIEW Obesity management for the hepatologist—What to do, how to do it and why? by @kymwatt @mqkMD et al. #LiverTwitter tinyurl.com/4kabwue9
- Original Article Efficacy and safety of infliximab in patients with autoimmune hepatitis Efe et al. #LiverX tinyurl.com/2nw4kbna
- REVIEW MetALD: Does it require a different therapeutic option? Marek GW & @hmalhi #LiverTwitter tinyurl.com/56ftmxvy
- REVIEW: Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management Allaire M & Thabut D. #LiverTwitter tinyurl.com/3xbrzd2x
- February @HEP_Journal: Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time? @sapisochin #TommyIvanics @JulieHeimbach #LiverTwitter bit.ly/33C2rDS
- REVIEW Noninvasive assessment of hepatic decompensation @MajaThiele et al. #LiverTwitter tinyurl.com/2ykcdxhk
- REVIEW: Mehta N et al. Refining the approach to down-staging of HCC prior to liver transplantation: Patient selection, loco-regional treatments, and systemic therapies. #LiverTwitter tinyurl.com/y7wy47dt
- REVIEW: Checkpoint inhibitor hepatotoxicity: pathogenesis and management Cunningham M; Gupta R; Butler M. #LiverTwitter tinyurl.com/55238xu6
- ORIGINAL ARTICLE Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized-trial Alvarado-Tapias et al. #LiverX tinyurl.com/2trhbnub

















